Search research articles
Contact Us
Filters
Showing results (161-170 of 189) with videos related to
Page
of 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation
Leisha A Emens, Justin M Asquith, James M Leatherman, et al.
Journal for Immunotherapy of Cancer
|
March 28, 2025
SITC strategic vision: prevention, premalignant immunity, host and environmental factors
Sasha E Stanton, Kristin G Anderson, Tullia C Bruno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2017
A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors
Jeffrey S Miller, Chihiro Morishima, Douglas G McNeel, et al.
NPJ Breast Cancer
|
November 9, 2019
If we build it they will come: targeting the immune response to breast cancer
Margaret E Gatti-Mays, Justin M Balko, Sofia R Gameiro, et al.
Nature Medicine
|
August 24, 2004
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
Tyler J Curiel, George Coukos, Linhua Zou, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Safety and immunogenicity of a tri-antigen vaccine targeting IGFBP-2, HER2, and IGF-IR in participants with non-metastatic breast cancer
Sasha E Stanton, Denise L Cecil, Howard H Bailey, et al.
Journal for Immunotherapy of Cancer
|
August 14, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer
Leisha A Emens, Sylvia Adams, Ashley Cimino-Mathews, et al.
Journal for Immunotherapy of Cancer
|
June 9, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
Mary L Disis, Sarah F Adams, Jyoti Bajpai, et al.
Cancer Research
|
April 5, 2017
Precancer Atlas to Drive Precision Prevention Trials
Avrum Spira, Matthew B Yurgelun, Ludmil Alexandrov, et al.
Cancer Immunology Research
|
August 14, 2014
Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma
Kelly G Paulson, Andrew Tegeder, Christoph Willmes, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 189) with videos related to
Sort By:
Page
of 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation
Leisha A Emens, Justin M Asquith, James M Leatherman, et al.
Journal for Immunotherapy of Cancer
|
March 28, 2025
SITC strategic vision: prevention, premalignant immunity, host and environmental factors
Sasha E Stanton, Kristin G Anderson, Tullia C Bruno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2017
A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors
Jeffrey S Miller, Chihiro Morishima, Douglas G McNeel, et al.
NPJ Breast Cancer
|
November 9, 2019
If we build it they will come: targeting the immune response to breast cancer
Margaret E Gatti-Mays, Justin M Balko, Sofia R Gameiro, et al.
Nature Medicine
|
August 24, 2004
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
Tyler J Curiel, George Coukos, Linhua Zou, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Safety and immunogenicity of a tri-antigen vaccine targeting IGFBP-2, HER2, and IGF-IR in participants with non-metastatic breast cancer
Sasha E Stanton, Denise L Cecil, Howard H Bailey, et al.
Journal for Immunotherapy of Cancer
|
August 14, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer
Leisha A Emens, Sylvia Adams, Ashley Cimino-Mathews, et al.
Journal for Immunotherapy of Cancer
|
June 9, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
Mary L Disis, Sarah F Adams, Jyoti Bajpai, et al.
Cancer Research
|
April 5, 2017
Precancer Atlas to Drive Precision Prevention Trials
Avrum Spira, Matthew B Yurgelun, Ludmil Alexandrov, et al.
Cancer Immunology Research
|
August 14, 2014
Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma
Kelly G Paulson, Andrew Tegeder, Christoph Willmes, et al.
Page
of 19